Herpes simplex virus 1 (HSV-1) establishes life-long infections of the human host characterized by productive infection of actively cycling epithelial cells and fibroblasts, and nonproductive latent infections of noncycling sensory neurons. Latent infections are characterized by the reactivation of productive cycle viral gene expression and new virus synthesis following stress. During the early stages of productive infection, viral immediate-early (IE) proteins act together to create a nuclear environment that promotes viral gene expression. Available evidence indicates that the phosphorylation of IE proteins by cyclin dependent kinases (cdks), other cellular kinases and viral kinases is responsible for the timely activation of IE protein functions. The expression of kinase activities in cycling cells during productive infection, the absence of these activities in noncycling latently infected neurons, and their induction in noncycling neurons following stress-induced reactivation, has led to the hypothesis that productive infection, reactivation and the activities of IE proteins are associated with the activities of these cdks and other kinases whereas latency is associated with their absence. Among HSV IE proteins, ICP0, ICP22 and ppUS1.5 have been shown to affect and be affected by cdks and their cyclin partners. These proteins confer a significant growth advantage on HSV-1 and are required for the efficient establishment and reactivation of latency. This proposal will test the hypothesis that the phosphorylation of ICP0, ICP22 and ppUS1.5 by cdks and other kinases expressed differentially in nonneuronal and neuronal cells affects the functional capabilities of these proteins during productive infection, latency and reactivation. For this purpose we will i) identify the sites on ICP0, ICP22 and ppUS1.5 that are phosphorylated and the cdks and other kinases that phosphorylate these sites, ii) test the effects of phosphorylation at selected sites by specific kinases on the functions of ICP0, ICP22 and ppUS1.5 in cell culture and during productive infection and latency and iii) examine the molecular basis for the ability of ICP22 and/or ppUSl.5 and phosphorylation site mutants thereof to inhibit the functions of ICP0. The information obtained in these studies will provide new insight into the molecular mechanism underlying HSV- 1 productive infection and latency and lead to novel approaches to intervening in the life-cycle of this clinically important virus.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA020260-33
Application #
7426451
Study Section
Experimental Virology Study Section (EVR)
Program Officer
Daschner, Phillip J
Project Start
1980-03-01
Project End
2011-05-31
Budget Start
2008-06-30
Budget End
2011-05-31
Support Year
33
Fiscal Year
2008
Total Cost
$387,594
Indirect Cost
Name
University of Arizona
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
806345617
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Mostafa, Heba H; Thompson, Thornton W; Kushnir, Anna S et al. (2011) Herpes simplex virus 1 ICP0 phosphorylation site mutants are attenuated for viral replication and impaired for explant-induced reactivation. J Virol 85:12631-7
Kushnir, Anna S; Davido, David J; Schaffer, Priscilla A (2010) Role of nuclear factor Y in stress-induced activation of the herpes simplex virus type 1 ICP0 promoter. J Virol 84:188-200
Bowman, J Jason; Orlando, Joseph S; Davido, David J et al. (2009) Transient expression of herpes simplex virus type 1 ICP22 represses viral promoter activity and complements the replication of an ICP22 null virus. J Virol 83:8733-43
Bowman, J Jason; Schaffer, Priscilla A (2009) Origin of expression of the herpes simplex virus type 1 protein U(S)1.5. J Virol 83:9183-94
Boutell, Chris; Everett, Roger; Hilliard, Joshua et al. (2008) Herpes simplex virus type 1 ICP0 phosphorylation mutants impair the E3 ubiquitin ligase activity of ICP0 in a cell type-dependent manner. J Virol 82:10647-56
Bringhurst, Ryan M; Dominguez, Antonia A; Schaffer, Priscilla A (2008) Glutamine deprivation causes enhanced plating efficiency of a herpes simplex virus type 1 ICP0-null mutant. J Virol 82:11472-5
Orlando, Joseph S; Balliet, John W; Kushnir, Anna S et al. (2006) ICP22 is required for wild-type composition and infectivity of herpes simplex virus type 1 virions. J Virol 80:9381-90
Bringhurst, Ryan M; Schaffer, Priscilla A (2006) Cellular stress rather than stage of the cell cycle enhances the replication and plating efficiencies of herpes simplex virus type 1 ICP0- viruses. J Virol 80:4528-37
Davido, David J; von Zagorski, William F; Lane, William S et al. (2005) Phosphorylation site mutations affect herpes simplex virus type 1 ICP0 function. J Virol 79:1232-43
Davido, David J; Von Zagorski, William F; Maul, Gerd G et al. (2003) The differential requirement for cyclin-dependent kinase activities distinguishes two functions of herpes simplex virus type 1 ICP0. J Virol 77:12603-16

Showing the most recent 10 out of 30 publications